Detalhe da pesquisa
1.
Vulnerability to APOBEC3G linked to the pathogenicity of deltaretroviruses.
Proc Natl Acad Sci U S A
; 121(13): e2309925121, 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38502701
2.
An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia/lymphoma.
Blood
; 141(10): 1159-1168, 2023 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36150143
3.
Anti-HTLV-1 immunity combined with proviral load as predictive biomarkers for adult T-cell leukemia-lymphoma.
Cancer Sci
; 115(1): 310-320, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37950425
4.
Whole-genome landscape of adult T-cell leukemia/lymphoma.
Blood
; 139(7): 967-982, 2022 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34695199
5.
Dose Individualization of Cefepime for Febrile Neutropenia in Patients With Lymphoma or Multiple Myeloma: Implications for Therapeutic Drug Monitoring.
Ther Drug Monit
; 46(1): 80-88, 2024 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37735762
6.
Long-term follow-up after R-High CHOP/CHASER/LEED with Auto-PBSCT in untreated mantle cell lymphoma-Final analysis of JCOG0406.
Cancer Sci
; 114(8): 3461-3465, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37232264
7.
In vivo dynamics and adaptation of HTLV-1-infected clones under different clinical conditions.
PLoS Pathog
; 17(2): e1009271, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33524072
8.
Integrated genetic and clinical prognostic factors for aggressive adult T-cell leukemia/lymphoma.
Haematologica
; 108(8): 2178-2191, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36794502
9.
Blocking cholesterol efflux mechanism is a potential target for antilymphoma therapy.
Cancer Sci
; 113(6): 2129-2143, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35343027
10.
Beneficial impact of first-line mogamulizumab-containing chemotherapy in adult T-cell leukaemia-lymphoma.
Br J Haematol
; 198(6): 983-987, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35607839
11.
Clinical significance of the immunoglobulin G heavy-chain repertoire in peripheral blood mononuclear cells of adult T-cell leukaemia-lymphoma patients receiving mogamulizumab.
Br J Haematol
; 196(3): 629-638, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34632569
12.
Genomic determinants impacting the clinical outcome of mogamulizumab treatment for adult T-cell leukemia/lymphoma.
Haematologica
; 107(10): 2418-2431, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35417939
13.
Systematic review of survival outcomes for relapsed or refractory adult T-cell leukemia-lymphoma.
Eur J Haematol
; 108(3): 212-222, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34862665
14.
[Follicular T-cell lymphoma successfully treated with long-term corticosteroid].
Rinsho Ketsueki
; 63(11): 1497-1502, 2022.
Artigo
em Japonês
| MEDLINE | ID: mdl-36476787
15.
[Adult T-cell leukemia/lymphoma diagnosed by RNA in situ hybridization for HTLV-1 bZIP factor].
Rinsho Ketsueki
; 63(2): 89-93, 2022.
Artigo
em Japonês
| MEDLINE | ID: mdl-35264507
16.
Adult T-cell leukemia-lymphoma as a viral disease: Subtypes based on viral aspects.
Cancer Sci
; 112(5): 1688-1694, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33630351
17.
Epidemiology of adult T-cell leukemia-lymphoma in Japan: An updated analysis, 2012-2013.
Cancer Sci
; 112(10): 4346-4354, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34355480
18.
Phase II study of tazemetostat for relapsed or refractory B-cell non-Hodgkin lymphoma with EZH2 mutation in Japan.
Cancer Sci
; 112(9): 3627-3635, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34159682
19.
Prophylactic antiviral therapy for hepatitis B virus surface antigen-positive patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy.
Cancer Sci
; 112(5): 1943-1954, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33576088
20.
Prognosis of patients with adult T-cell leukemia/lymphoma in Japan: A nationwide hospital-based study.
Cancer Sci
; 111(12): 4567-4580, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32976684